What is the recommended dose of 18F‑NOTANOC for an adult patient undergoing PET imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

18F-NOTANOC Dosing for Adult PET Imaging

The recommended dose of 18F-NOTANOC for adult patients is 185-370 MBq (5-10 mCi) administered intravenously, with imaging initiated within 40 minutes of injection 1.

Dosing Specifications

The FDA-approved dosing range provides flexibility based on patient characteristics and imaging equipment:

  • Standard adult dose (70 kg): 185-370 MBq (5-10 mCi) IV
  • Dose calculation: Should be measured using a suitable radioactivity calibration system before administration, with proper decay factors applied from time of end-of-synthesis 1
  • Timing: PET imaging should begin within 40 minutes of tracer injection 1

Patient Preparation Considerations

While the FDA label for 18F-NOTANOC references FDG preparation protocols, key preparation steps include:

  • Blood glucose stabilization: Fasting is recommended for non-diabetic patients; diabetic patients may require glucose stabilization on the day preceding and day of scan 1
  • Adequate hydration: Important for optimal biodistribution and renal clearance

Radiation Dosimetry

The effective dose for this class of radiopharmaceuticals is approximately 2.02E-02 mSv/MBq 2, making the total effective dose for a standard 185-370 MBq administration range from 3.7-7.5 mSv from the PET component alone. Additional radiation exposure from CT must be factored into total patient dose.

Administration Protocol

  • Administer through IV line with aseptic technique
  • Use waterproof gloves and effective shielding when handling
  • Store upright in lead-shielded environment at controlled room temperature
  • Inspect visually for particulate matter or discoloration before administration 1

Timing Between Doses

Allow sufficient time for substantial physical and biological decay of previous administrations before repeat dosing 1. The optimum interval has not been formally established but should account for the 110-minute physical half-life of F-18.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.